Medical Cannabis Related News
Currency UK: helping cannabis businesses with international payments
Currency UK specialises in the movement of money internationally for cannabis businesses, and offers competitive exchange rates with zero fees.
Currency UK specialises in the...
Kalytera Therapeutics: improving bone marrow transplants with CBD
Dr Sari Prutchi Sagiv, CSO at Kalytera Therapeutics Inc., showcases the potential of CBD to revolutionise treatment of Graft versus Host Disease.
The development of...
New Frontier Data launches first virtual Global Cannabis Town Hall
Amidst the current global COVID-19 outbreak and the ensuing cancellation of all conferences, New Frontier Data will be holding a virtual Global Cannabis Town...
New study shows that CBD improves efficacy of antibiotics
A new study has shown that the cannabis cannabinoid CBD helps to fight resistant bacteria by improving the efficacy of antibiotics.
Scientists at the University...
Mapping the cannabis genome: developing a genetic blueprint for breeding
A major analysis of statistical data and studies has highlighted the importance of mapping the cannabis genome for unlocking the full potential of the...
Drug Science partnership to improve patient access to medical cannabis
Drug Science Medical Cannabis Working Group has formed a partnership with a leading British producer of medical cannabis to help improve patients access to...
First study to look at the use of cannabinoids for treating acute pain
A new review has shown that further research is needed into the use of cannabinoids in the treatment of acute pain.
The only peer-reviewed journal...
Rize ETF: Europe’s most diversified cannabis equity portfolio
Four new companies have been added to Rize ETF’s specialist thematic Exchange Traded Fund (ETF) to create Europe’s most diversified cannabis equity portfolio.
Rize ETF,...
Symtomax: poised for a head start in the European cannabis market
A Portuguese cannabis company, Symtomax, is positioning itself to become the biggest supplier of medical cannabis in the European cannabis market.
Symtomax, a medical cannabis...
Expert answers: can cannabis and CBD affect coronavirus?
In this article, integrative medicine expert, Dr Dani Gordon, answers peoples’ question of whether cannabis and CBD can affect contracting or recovering from COVID-19,...
Landmark move opens patient access to online cannabis consultations
Patients in the UK are one step closer to comprehensive medical cannabis access thanks to new online video consultations.
Sapphire Medical Clinics has become the...
Cymra Life Sciences: pioneering tissue culture for novel pain medicines
Cymra Life Sciences is pioneering plant science research to create superior cannabis pain relief medicines.
Australian life sciences company Cymra Life Sciences is harnessing science...
CanPharma: bridging the gap between plant and patients
With a team of medical experts and seasoned pharmaceutical entrepreneurs, CanPharma is set to drive innovation and to set new standards for optimal treatment...
CBD Export Global: streamlining global cannabis
CBD Export Global sets the international standard in sourcing, processing and supplying compliant hemp and cannabis ingredients for manufacturing consumer packaged goods.
CBD Export Global...
Arge Canna: medical cannabis lobbying and patient advocacy in Austria
Mag. Klaus Hübner of patient advocacy body Arge Canna tells MCN about Austria’s medical cannabis legislation and Arge Canna’s campaigns.
Arge Canna is the primary...
The NCIA talks policy, equality and regulation in US cannabis
National Cannabis Industry Association Media Relations Director Morgan Fox tells MCN about regulation, policy reform and representation in the field of US cannabis.
The National...
LeafCann: common misconceptions about cannabis
LeafCann Group CEO Elisabetta Faenza explores harmful myths around medical and adult use cannabis.
Leafcann is aware that perhaps no other plant causes as much...
Rize ETF: separating the medical cannabis science from the hype
Rahul Bhushan, co-founder of European exchange-traded fund issuer Rize ETF, discusses global trends in medical cannabis regulation.
The world of cannabis is full of unlikely...
Medicaleaf: the clarion call for wellness from nature
The Medicaleaf team share their observations and understanding of the driving forces of increasing consumer demand for CBD.
Medicaleaf™ aspires to be a philanthropic and...
Emerald Clinics: co-creating evidence with medical cannabis patients
Emerald Clinics CEO Dr Michael Winlo highlights the unique benefits of building real world evidence bases in patient-focussed clinical practice.
Emerald Clinics' asks 'why haven’t...